ProMIS Neurosciences, Inc.
PMN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $8 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $10,445 | $0 | $5,851 |
| Gross Profit | $0 | -$10,445 | $0 | -$5,843 |
| % Margin | – | – | – | -71,796.9% |
| R&D Expenses | $10,638 | $7,883 | $16,087 | $4,949 |
| G&A Expenses | $6,190 | $7,393 | $7,293 | $3,313 |
| SG&A Expenses | $6,190 | $6,380 | $7,293 | $3,313 |
| Sales & Mktg Exp. | $0 | -$1,013 | $0 | $0 |
| Other Operating Expenses | $0 | -$5,810 | $0 | $0 |
| Operating Expenses | $16,827 | $8,453 | $23,380 | $8,263 |
| Operating Income | -$16,827 | -$18,898 | -$23,380 | -$8,250 |
| % Margin | – | – | – | -101,363.6% |
| Other Income/Exp. Net | $19,606 | $1,392 | $5,318 | -$1,499 |
| Pre-Tax Income | $2,779 | -$17,506 | -$18,062 | -$9,243 |
| Tax Expense | $0 | $0 | $0 | $415 |
| Net Income | $2,779 | -$17,506 | -$18,062 | -$9,658 |
| % Margin | – | – | – | -118,662.2% |
| EPS | 2.75 | -35.5 | -42.5 | -41.75 |
| % Growth | 107.7% | 16.5% | -1.8% | – |
| EPS Diluted | 2.75 | -35.5 | -42.5 | -41.75 |
| Weighted Avg Shares Out | 1,037 | 492 | 300 | 231 |
| Weighted Avg Shares Out Dil | 1,058 | 492 | 300 | 231 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $5 |
| Interest Expense | $77 | $201 | $282 | $416 |
| Depreciation & Amortization | $0 | $28 | $11 | $46 |
| EBITDA | $2,856 | -$17,810 | -$17,769 | -$9,328 |
| % Margin | – | – | – | -114,612.9% |